Quanterix (QTRX) Gains from Investment Securities (2017 - 2026)
Quanterix (QTRX) posted Gains from Investment Securities of -$1.5 million for Q1 2026, down 152.27% on a QoQ basis from -$595000.0 in Q4 2025, and down 496.04% year-over-year from $379000.0 in Q1 2025.
Quanterix (QTRX) Gains from Investment Securities (2017 - 2026) Analysis & Trends
Quanterix's Gains from Investment Securities history runs 4 years deep, the most recent figure standing at -$1.5 million for Q1 2026.
- Quarterly Gains from Investment Securities fell 496.04% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.4 million (down 1795.78% YoY) and the FY2025 annual result came in at -$4.5 million, changed N/A from the prior year.
- Gains from Investment Securities was -$1.5 million for Q1 2026 at Quanterix, down from -$595000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $379000.0 in Q1 2025 and bottomed at -$4.3 million in Q2 2025.
- A 3-year average of -$893285.7 and a median of -$359000.0 in 2023 frame the typical range for Gains from Investment Securities.
- Peak annual rise in Gains from Investment Securities reached 496.04% in 2026, while the deepest fall reached 496.04% in 2026.
- Quanterix's Gains from Investment Securities stood at -$359000.0 in 2023, then slumped by 65.74% to -$595000.0 in 2025, then plunged by 152.27% to -$1.5 million in 2026.
- Business Quant data shows QTRX's Gains from Investment Securities at -$1.5 million in Q1 2026, -$595000.0 in Q4 2025, and -$58000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn |
| 10 | Quanterix | 174.53 Mn | 75.26 Mn | 15.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.50 Mn |
| Mar 31, 2026 | -1.50 Mn |
| Dec 31, 2025 | -595,000.00 |
| Dec 31, 2025 | -595,000.00 |
| Sep 30, 2025 | -58,000.00 |
| Sep 30, 2025 | -58,000.00 |
| Jun 30, 2025 | -4.27 Mn |
| Jun 30, 2025 | -4.27 Mn |
| Mar 31, 2025 | 379,000.00 |
| Mar 31, 2025 | 379,000.00 |
| Dec 31, 2023 | -359,000.00 |
| Dec 31, 2023 | -359,000.00 |
| Sep 30, 2023 | 154,000.00 |
| Sep 30, 2023 | 154,000.00 |
| Dec 31, 2017 | 152,000.00 |
| Dec 31, 2017 | 152,000.00 |
| Sep 30, 2017 | -31,000.00 |
| Sep 30, 2017 | -31,000.00 |
| Jun 30, 2017 | -99,000.00 |
| Jun 30, 2017 | -99,000.00 |